Dyslipidemia is a common nutritional and metabolic disorder in patients with chronic kidney
disease. Accumulating evidence supports the hypothesis that prolonged metabolic …

Non-alcoholic fatty liver disease (NAFLD), which is emerging as a major public health issue
worldwide, is characterized by a wide spectrum of liver disorders, ranging from simple fat …

Obesity, a major health problem worldwide, is associated with increased cardiovascular risk
factors, such as dyslipidemia, glucose intolerance, and hypertension. We investigated the …

Background Citrus flavonoids, consisting of naringin, narirutin, neohesperidine, etc., have
therapeutic activities for the treatment of lipometabolic disorders. The peel of Citrus …

Metabolic syndrome (MetS) represents a set of clinical findings that include visceral
adiposity, insulin-resistance, high triglycerides (TG), low high-density lipoprotein cholesterol …

Abstract Background and aim Non-Alcoholic Fatty Liver Disease (NAFLD) represents a risk
factor for cardiovascular diseases. NAFLD is worsened by the simultaneous occurrence of …

Neuropathic pain is a chronic painful disease. Data have shown that reactive oxygen
species (ROS) are implicated in chronic pain. Particularly, the enhanced ROS production …

Chronic inflammation is the result of an acute inflammatory response that fails to eliminate
the pathogenic agent or heal the tissue injury. The consequence of this failure lays the …

The control of neuropathic pain is a leading challenge in modern medicine. Traditional
medicine has, for a long time, used natural compounds such as nutraceuticals for this …

Obesity is a potent risk factor for kidney disease as it increases the possibility of developing
diabetes and hypertension, and it has a direct impact on the development of chronic kidney …